246 related articles for article (PubMed ID: 36359790)
21. MYC protein is a high-risk factor in mantle cell lymphoma and identifies cases beyond morphology, proliferation and
Rodrigues JM; Hollander P; Schmidt L; Gkika E; Razmara M; Kumar D; Geisler C; Grønbæk K; Eskelund CW; Räty R; Kolstad A; Sundström C; Glimelius I; Porwit A; Jerkeman M; Ek S
Haematologica; 2024 Apr; 109(4):1171-1183. PubMed ID: 37646663
[TBL] [Abstract][Full Text] [Related]
22. MiR-132-3p serves as a tumor suppressor in mantle cell lymphoma via directly targeting SOX11.
Wu B; Li J; Wang H; Wu Q; Liu H
Naunyn Schmiedebergs Arch Pharmacol; 2020 Nov; 393(11):2197-2208. PubMed ID: 32040593
[TBL] [Abstract][Full Text] [Related]
23. [Clinicopathologic features and prognosis of gastrointestinal mantle cell lymphoma].
Hou WH; Wei P; Xie JL; Zheng YY; Zhang YL; Zhou XG
Zhonghua Bing Li Xue Za Zhi; 2018 Oct; 47(10):763-768. PubMed ID: 30317731
[No Abstract] [Full Text] [Related]
24. Identification of the SRC-family tyrosine kinase HCK as a therapeutic target in mantle cell lymphoma.
Lantermans HC; Minderman M; Kuil A; Kersten MJ; Pals ST; Spaargaren M
Leukemia; 2021 Mar; 35(3):881-886. PubMed ID: 32591642
[TBL] [Abstract][Full Text] [Related]
25. USP9X Increased Tumor Angiogenesis in Mantle Cell Lymphoma by Upregulation of CCND1-Mediated SOX11.
Huang G; Liao J; Wang M; Huang Y; Tang M; Hao Y
Mediterr J Hematol Infect Dis; 2022; 14(1):e2022048. PubMed ID: 35865393
[TBL] [Abstract][Full Text] [Related]
26. SOX11, a key oncogenic factor in mantle cell lymphoma.
Beekman R; Amador V; Campo E
Curr Opin Hematol; 2018 Jul; 25(4):299-306. PubMed ID: 29738333
[TBL] [Abstract][Full Text] [Related]
27. Mantle cell lymphoma with chronic lymphocytic leukemia-like features: a diagnostic mimic and pitfall.
Qiu L; Xu J; Tang G; Wang SA; Lin P; Ok CY; Garces S; Yin CC; Khanlari M; Vega F; Medeiros LJ; Li S
Hum Pathol; 2022 Jan; 119():59-68. PubMed ID: 34767860
[TBL] [Abstract][Full Text] [Related]
28. Mantle cell lymphoma: transcriptional regulation by microRNAs.
Di Lisio L; Gómez-López G; Sánchez-Beato M; Gómez-Abad C; Rodríguez ME; Villuendas R; Ferreira BI; Carro A; Rico D; Mollejo M; Martínez MA; Menárguez J; Díaz-Alderete A; Gil J; Cigudosa JC; Pisano DG; Piris MA; Martínez N
Leukemia; 2010 Jul; 24(7):1335-42. PubMed ID: 20485376
[TBL] [Abstract][Full Text] [Related]
29. LncRNA LUADT1 is Upregulated in Mantle Cell Lymphoma and Modulates TRIM11 by Sponging miR-24-3p to Inhibit Cell Apoptosis.
Dong L; Zhang H; Zan T; Han J; Xue Q; Sun Y
Crit Rev Eukaryot Gene Expr; 2021; 31(5):33-40. PubMed ID: 34591388
[TBL] [Abstract][Full Text] [Related]
30. CD23 expression in mantle cell lymphoma is associated with CD200 expression, leukemic non-nodal form, and a better prognosis.
Saksena A; Yin CC; Xu J; Li J; Zhou J; Wang SA; Lin P; Tang G; Wang L; Wang M; Miranda RN; Medeiros LJ; Li S
Hum Pathol; 2019 Jul; 89():71-80. PubMed ID: 31054894
[TBL] [Abstract][Full Text] [Related]
31. Tumorigenic role of Musashi-2 in aggressive mantle cell lymphoma.
Sureda-Gómez M; Balsas P; Rodríguez ML; Nadeu F; De Bolòs A; Eguileor Á; Kulis M; Castellano G; López C; Giné E; Demajo S; Jares P; Martín-Subero JI; Beà S; Campo E; Amador V
Leukemia; 2023 Feb; 37(2):408-421. PubMed ID: 36509891
[TBL] [Abstract][Full Text] [Related]
32. High level of cannabinoid receptor 1, absence of regulator of G protein signalling 13 and differential expression of Cyclin D1 in mantle cell lymphoma.
Islam TC; Asplund AC; Lindvall JM; Nygren L; Liden J; Kimby E; Christensson B; Smith CI; Sander B
Leukemia; 2003 Sep; 17(9):1880-90. PubMed ID: 12970790
[TBL] [Abstract][Full Text] [Related]
33. Association of SOX11 gene expression withclinical features and prognosis of mantle cell lymphoma.
He JX; Xi YF; Su LP; Gao N; Xu EW; Xie LW; Wang LY; Zheng YP; Han WE; Chang J; Wang HW
Eur Rev Med Pharmacol Sci; 2018 May; 22(9):2556-2563. PubMed ID: 29771407
[TBL] [Abstract][Full Text] [Related]
34. Whole-Transcriptome RNA Sequencing Reveals Significant Differentially Expressed mRNAs, miRNAs, and lncRNAs and Related Regulating Biological Pathways in the Peripheral Blood of COVID-19 Patients.
Li CX; Chen J; Lv SK; Li JH; Li LL; Hu X
Mediators Inflamm; 2021; 2021():6635925. PubMed ID: 33833618
[TBL] [Abstract][Full Text] [Related]
35. Advances and issues in mantle cell lymphoma research: report of the 2014 Mantle Cell Lymphoma Consortium Workshop.
Kahl BS; Gordon LI; Dreyling M; Gascoyne RD; Sotomayor EM
Leuk Lymphoma; 2015; 56(9):2505-11. PubMed ID: 25944379
[TBL] [Abstract][Full Text] [Related]
36. SOX11/PRDX2 axis modulates redox homeostasis and chemoresistance in aggressive mantle cell lymphoma.
De Bolòs A; Sureda-Gómez M; Carreras-Caballé M; Rodríguez ML; Clot G; Beà S; Giné E; Campo E; Balsas P; Amador V
Sci Rep; 2024 Apr; 14(1):7863. PubMed ID: 38570586
[TBL] [Abstract][Full Text] [Related]
37. Leukemic Variant of Mantle Cell Lymphoma: Clinical Presentation and Management.
Isaac KM; Portell CA; Williams ME
Curr Oncol Rep; 2021 Jul; 23(9):102. PubMed ID: 34269910
[TBL] [Abstract][Full Text] [Related]
38. Transcriptome sequencing in Sezary syndrome identifies Sezary cell and mycosis fungoides-associated lncRNAs and novel transcripts.
Lee CS; Ungewickell A; Bhaduri A; Qu K; Webster DE; Armstrong R; Weng WK; Aros CJ; Mah A; Chen RO; Lin M; Sundram U; Chang HY; Kretz M; Kim YH; Khavari PA
Blood; 2012 Oct; 120(16):3288-97. PubMed ID: 22936659
[TBL] [Abstract][Full Text] [Related]
39. Elevated SOX11 mRNA level correlates with favorable prognosis in mantle cell lymphoma.
He J; Xi Y; Gao N; Xu E; Xie L; Chang J; Liu J
J BUON; 2019; 24(4):1679-1685. PubMed ID: 31646825
[TBL] [Abstract][Full Text] [Related]
40. The Wnt signaling pathway and mitotic regulators in the initiation and evolution of mantle cell lymphoma: Gene expression analysis.
Kimura Y; Arakawa F; Kiyasu J; Miyoshi H; Yoshida M; Ichikawa A; Niino D; Sugita Y; Okamura T; Doi A; Yasuda K; Tashiro K; Kuhara S; Ohshima K
Int J Oncol; 2013 Aug; 43(2):457-68. PubMed ID: 23760751
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]